Dr. Natalie Garg

Angestellt, Projektmanagerin Strategischer Einkauf, Limbach Gruppe SE

Heidelberg, Deutschland

Fähigkeiten und Kenntnisse

Onkologie
Immunologie
Antikörper
Protein Engineering
Project management
Selbstständigkeit
Organisationstalent

Werdegang

Berufserfahrung von Natalie Garg

  • Bis heute 3 Jahre und 4 Monate, seit März 2021

    Projektmanagerin Strategischer Einkauf

    Limbach Gruppe SE

  • 4 Jahre und 3 Monate, Dez. 2015 - Feb. 2020

    PhD Student

    Deutsches Krebsforschungszentrum DKFZ Heidelberg

    Department of Antibody- and Cell-based Immunotherapeutics, Medical Oncology - Development of immunomodulating antibodies and incorporation in CAR T-cell therapy - Independent project development and patent research - Process optimization, introduction of SOP-structure - Managing cooperations with external partners - Presentation of results on external symposia - Scientific talks for students, supervision of master students - Funded by a 3 year Helmholtz International Graduate School PhD stipend

  • 5 Monate, Aug. 2014 - Dez. 2014

    Praktikantin

    Roche in Deutschland

    - Investigation of resistance mechanisms to cytolytic fusion proteins in cancer therapy using cell-based assays

  • 3 Monate, Juni 2013 - Aug. 2013

    Praktikantin

    University of Oxford, Sir William Dunn School of Pathology

    - Studying transcriptional regulation in neurodegenerative repeat expansion disease - Funded by a scholarship of the German Academic Exchange Service (DAAD)

  • 3 Monate, Juli 2012 - Sep. 2012

    Praktikantin

    University of British Columbia, Dep. of Cellular and Physiological Sciences

    - Characterization of a model of high-fat diet induced diabetes in mice - Analysis of the role of gastrointestinal hormones during pancreas development - Funded by a scholarship of the German Academic Exchange Service (DAAD)

Ausbildung von Natalie Garg

  • 4 Jahre und 3 Monate, Dez. 2015 - Feb. 2020

    Biological Sciences

    Ruprecht-Karls-Universität Heidelberg

    - Development of immunomodulating antibodies and incorporation in CAR T-cell therapy - Independent project development - Process optimization - Presentation of results on external symposia - 3 year Helmholtz International Graduate School PhD stipend

  • 2013 - 2015

    Onkologie

    Ruprecht-Karls-Universität Heidelberg

    - Molecular cancer biology - Master`s thesis: identification of lead candidate antibodies using phage display and the characterization of antibodies for immune-checkpoint blockade

  • 2010 - 2013

    Biological Sciences

    Ruprecht-Karls-Universität Heidelberg

    - Bachelor´s thesis focused on cancer stem cells and the role of CD95 in cancer-related inflammation

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Russisch

    Grundlagen

21 Mio. XING Mitglieder, von A bis Z